Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Talk about a taste of our own medicine
This phase 3 trial directly compares CagriSema 2.4 mg/2.4 mg against tirzepatide 15 mg in approximately 800 adults with obesity
CJC-1295 binds the GHRH receptor on pituitary somatotrophs while Ipamorelin acts on the distinct GHS-R1a (ghrelin) receptor, producing synergistic, pulsatile GH release in animal models
Gastrointestinal Protection: Bepecin strengthens the gut lining and stimulates blood flow to the intestines
US$ 22.40
US$ 22.24
US$ 22.44
US$ 24.64
US$ 29.32
